Shibolet & Co. is ‘an exceptional legal practice for start-ups’, and it boasts a diverse client base that also includes hit-tech companies, incubators, investors, VC funds, research institutes, HMOs, and more. Focused predominantly on corporate and investment transactions, the firm also supports clients in the healthcare and life sciences sectors with regulatory, IP, antitrust, and litigation advice. Regulatory expert Ofer Ben-Yehuda and hi-tech investment specialist Einat Weidberg are the lead partners. Regulatory and crisis management specialist Amos Bentzur is a key adviser to HMOs and pharmaceutical companies.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Shibolet & Co. is an exceptional legal practice for start-ups. What makes them stand out is their deep understanding of the challenges early-stage companies face, particularly in fundraising.'
- 'Shibolet & Co has the unique ability to maintain the highest level of professionalism, while adapting to the communication styles and expectations of their business partners.'
Key clients
- Biontech SE
- Lts Pharmaceutical Solutioms
- Jiangsu Aiyimu Medtech Co., Ltd.
- Second Skin
- Dele Health Tech As
- China-Israel Biological Technology Co., Ltd.
- Noya Therapeutics Limited
- American Ortho
- Grindeks
- Gilead Sciences Israel
- Innovestgenetics Gmbh
- Lexington Medical Inc
- Pregnantech LTD
- Chengdu Kanghong Pharmaceutical Co., Ltd.
- OBCTCD 24 Ltd.
- Pluristem Ltd.
- Nobio Ltd
- VUZE medical
- CartiHeal (2009) Ltd.
- The Trendlines Group Ltd.
- Elron Electronic Industries Ltd.
- Alon Medtech Ventures Ltd.
- BeyeOnics Surgical Ltd.
- OrthoSpin Ltd.
- NovoCure (Israel) Ltd.
- Technion Research and Development Foundation Ltd.
- Technion Investment Opportunities Fund
- Ancora Medical
- ApiFix Ltd.
- RDD Pharma Ltd.
- Compugen Ltd.
- DiA Imaging Analysis Ltd.
- Ballet Vision Ltd.
- Emulait Inc.
- Clalit Health Services
- Pi-Cardia Ltd.
- Ever After Foods
- Endymed Medical Ltd.
- Microbot Medical Inc.
- Clanz Technologies Ltd.
- Pluri Biotech Ltd.
- Rimonci International Specialized Fund Ltd.
Work highlights
- Represented CartiHeal (2009) Ltd., in its sale to Bioventus LLC and the return to original shareholders after that deal’s termination.
- Represented Rimonci and VTI, major shareholders of Belkin Vision Ltd., in its sale to Alcon Pharmaceuticals Ltd. for up to US$330m, including earn-out payments, through a Merger Agreement.
- Advised Compugen, a clinical-stage company that uses predictive computational discovery to develop cancer immunotherapies, on a US$50m public offering of shares on the Nasdaq via an At-The-Market sale mechanism and provided ongoing consulting for Compugen on various matters, including corporate governance, securities law, compensation, etc.
Practice head
The lawyer(s) leading their teams.
Ofer Ben-Yehuda, Einat Weidberg